3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Prostatic Neoplasms
3
Recurrence
1
Ovarian Neoplasms
1
Mesothelioma
1
Kidney Neoplasms
1
Fallopian Tube Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Renal Cell
1
Interventions
Carboplatin
75
Paclitaxel
68
Bevacizumab
44
Taxes
22
Cyclophosphamide
21
pembrolizumab
19
Gemcitabine
19
Cisplatin
18
Topotecan
17
Hyperthermic Intraperitoneal Chemotherapy
14
olaparib
13
liposomal doxorubicin
13
Immunoglobulin G
13
Disulfides
13
Specimen Handling
11
Drug Therapy
11
niraparib
10
Cytoreduction Surgical Procedures
10
Magnetic Resonance Spectroscopy
9
sargramostim
7
Surveys and Questionnaires
7
Doxorubicin
7
Docetaxel
7
durvalumab
6
Platinum
6
Nivolumab
6
Letrozole
6
Granulocyte-Macrophage Colony-Stimulating Factor
6
Biopsy
6
Albumin-Bound Paclitaxel
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Fallopian Tube Neoplasms
×
TroVax
×
Clear all
NCT01556841
2019-05-09
TRIOC
University College, London
Phase 2
Completed
94 enrolled